Home
Reels
Groups
Pages
See More
Groups Pages Events Blogs Jobs Forums
Sign In Sign Up
Day Mode
How the Bevacizumab Biosimilar Market Is Reshaping Oncology Treatment
The Bevacizumab Biosimilar Market is experiencing substantial growth as healthcare systems worldwide seek cost-effective alternatives to expensive biologic cancer therapies. Bevacizumab, a monoclonal antibody that inhibits vascular endothelial growth factor (VEGF), has been a cornerstone treatment for multiple cancer types including colorectal, lung, breast, ovarian, and glioblastoma. However,...
0 Comments ·0 Shares ·40 Views
Please log in to like, share and comment!
Lukoon https://lukoon.com